Trials / Terminated
TerminatedNCT02335216
A Post Market Study on Dorsal Root Ganglion (DRG) Stimulation in Failed Back Surgery Syndrome (FBSS)
A Post Market ObServational StudY on the Effect of DRG StiMulation in PATients witH Chronic Pain Following Surgical Lumbar DiscectomY (Failed Back Surgery Syndrome): SYMPATHY
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
18-SMI-2013 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic pain following lumbar discectomy (Failed Back Surgery Syndrome)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation with the commercially available Axium neurostimulator |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2015-01-09
- Last updated
- 2019-10-16
- Results posted
- 2018-03-26
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02335216. Inclusion in this directory is not an endorsement.